bioRxivImmunology
Molecular basis of a dominant SARS-CoV-2 Spike-derived epitope presented by HLA-A*02:01 recognised by a public TCR
C. Szeto, A. T. Nguyen, C. A. Lobos, D. S. Chatzileontiadou, D. Jayasinghe, E. J. Grant, A. Riboldi-Tunnicliffe, C. Smith, S. Gras
Abstract
The data currently available on how the immune system recognizes the SARS-CoV-2 virus is growing rapidly. While there are structures of some SARS-CoV-2 proteins in complex with antibodies, which helps us understand how the immune system is able to recognise this new virus, we are lacking data on how T cells are able to recognize this virus. T cells, especially the cytotoxic CD8+ T cells, are critical for viral recognition and clearance. Here we report the X-ray crystallography structure of a T cell receptor, shared among unrelated individuals (public TCR) in complex with a dominant spike-derived CD8+ T cell epitope (YLQ peptide). We show that YLQ activates a polyfunctional CD8+ T cell response in COVID-19 recovered patients. We detail the molecular basis for the shared TCR gene usage observed in HLA-A*02:01+ individuals, providing an understanding of TCR recognition towards a SARS-CoV-2 epitope. Interestingly, the YLQ peptide conformation did not change upon TCR binding, facilitating the high-affinity interaction observed.
- organism: virus
- assay: structural biology
- research focus: host-pathogen & immune response
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Structural basis for recognition of two HLA-A2-restricted SARS-CoV-2 spike epitopes by public and private T cell receptors
D. Wu, A. Kolesnikov, … R. A. Mariuzza·bioRxiv·Jul 28, 2021
- CD8+ T cell epitope variations suggest a potential antigen presentation deficiency for spike protein of SARS-CoV-2
- Identification, crystallization and epitope determination of public TCR shared and expanded in COVID-19 patients
X. Lu, Y. Hosono, … S. Yamasaki·bioRxiv·Mar 23, 2021
- Uncovering structural determinants of peptide recognition by public and private T-cell receptors
Caner Akıl, Yanchun Peng, … Peijun Zhang·bioRxiv·Nov 23, 2025
- Broadly-recognized, cross-reactive SARS-CoV-2 CD4 T cell epitopes are highly conserved across human coronaviruses and presented by common HLA alleles
A. Becerra-Artiles, J. M. Calvo-Calle, … L. J. Stern·bioRxiv·Jan 20, 2022
- Characterization of SARS-CoV-2 public CD4+ αβ T cell clonotypes through reverse epitope discovery
E. Rosati, M. V. Pogorelyy, … P. Thomas·bioRxiv·Nov 19, 2021